soul study semaglutide Updates in Medicine | 🩺 Oral Cuts CV Risk in High-Risk T2DM – Trial (NEJM, Mar 2025) 🔗 Original article link in bio 📌 Key Highlights: 🔹 soul trial oral semaglutide cardiovascular

At the maintenance stage, semaglutide is meant to help you hold onto the progress youve already made

Human Growth Hormone and Anti-Aging

Patients should be advised to: Start with the lowest dose and increase slowly Eat smaller, more frequent meals Avoid high-fat foods Stay well-hydrated Safety monitoring should include vigilance for: Pancreatitis symptoms (severe persistent abdominal pain) discontinue immediately if suspected Gallbladder disease increased risk with rapid weight loss Hypoglycaemia particularly when combined with insulin or sulphonylureas Renal function deterioration especially with dehydration from gastrointestinal effects Diabetic retinopathy monitor in patients with pre-existing retinopathy, particularly with semaglutide Suspected adverse reactions should be reported via the MHRA Yellow Card scheme

Three well-known weight loss injections include Semaglutide, Mounjaro, and Kybella

This is due to their effectiveness in managing type 2 diabetes and promoting weight loss

Semaglutide may also support cardiovascular health by improving lipid profiles and reducing atherosclerotic risk